Cargando…
Squalene epoxidase/SQLE is a candidate target for treatment of colorectal cancers with p53 mutation and elevated c-MYC expression
Elevated expression of c-MYC and inactivation of p53 represent two of the most common alterations in colorectal cancer (CRC). However, c-MYC and defective p53 are difficult to target therapeutically. Therefore, effectors downstream of both c-MYC and p53 may represent attractive, alternative targets...
Autores principales: | Du, Yuyun, Rokavec, Matjaz, Hermeking, Heiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496509/ https://www.ncbi.nlm.nih.gov/pubmed/37705742 http://dx.doi.org/10.7150/ijbs.85724 |
Ejemplares similares
-
Emergence of Terbinafine Resistant Trichophyton mentagrophytes in Iran, Harboring Mutations in the Squalene Epoxidase (SQLE) Gene
por: Taghipour, Simin, et al.
Publicado: (2020) -
p53 and MYC-regulated squalene epoxidase as Achilles heel in colorectal cancer
por: Fischer, Martin
Publicado: (2023) -
Novel Insight into the Role of Squalene Epoxidase (SQLE) Gene in Determining Milk Production Traits in Buffalo
por: Chen, Chao, et al.
Publicado: (2023) -
Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis
por: Rokavec, Matjaz, et al.
Publicado: (2019) -
Functional characterization of squalene synthase and squalene epoxidase in Taraxacum koksaghyz
por: Unland, Kristina, et al.
Publicado: (2018)